Quick Answer
Chemours Co reported Stockholders Equity of $250.00 million for fiscal year 2025.
Chemours Co Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $250.00M | -8.8% |
| 2025 | $274.00M | +20.2% |
| 2025 | $228.00M | -59.7% |
| 2025 | $566.00M | -0.9% |
| 2024 | $571.00M | -20.8% |
| 2023 | $721.00M | -3.7% |
| 2023 | $749.00M | -32.3% |
| 2022 | $1.11B | +2.4% |
| 2021 | $1.08B | +33.0% |
| 2020 | $813.00M | +18.0% |
| 2019 | $689.00M | -32.1% |
| 2018 | $1.01B | +17.9% |
| 2017 | $860.00M | +760.0% |
| 2016 | $100.00M | -20.6% |
| 2015 | $126.00M | -96.6% |
| 2014 | $3.67B | +14.1% |
| 2013 | $3.22B | +1.6% |
| 2012 | $3.17B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $298.00M | -53.7% | +25.7% |
| June 30, 2025 | $237.00M | -66.8% | -59.1% |
| March 31, 2025 | $579.00M | -23.1% | -1.4% |
| December 31, 2024 | $587.00M | -20.2% | -8.7% |
| September 30, 2024 | $643.00M | -14.8% | -9.9% |
| June 30, 2024 | $714.00M | -11.6% | -5.2% |
| March 31, 2024 | $753.00M | -38.6% | +2.3% |
| December 31, 2023 | $736.00M | -33.5% | -2.5% |
- Chemours Co showed a decrease of -8.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Chemours Co’s stockholders equity has declined by 92.1% (from $3.17 billion to $250.00 million).
- The most recent figure is from Chemours Co’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: